%0 Journal Article
%T 白血病免疫治疗靶点研究进展<br>Current Research Advance in Immunotherapy of Leukemia
%A 唐瑀彤
%A 朱小瑛
%A 游泳
%J World Journal of Cancer Research
%P 7-15
%@ 2164-9057
%D 2022
%I Hans Publishing
%R 10.12677/WJCR.2022.121002
%X 白血病是一类造血干/祖细胞的恶性克隆性疾病，其治疗方法主要有化学治疗、造血干细胞移植、免疫治疗和分子靶向治疗等。近年来，白血病的免疫治疗取得了重大突破，成为研究热点，尤其是嵌合抗原受体修饰T细胞(chimeric antigen receptor T cells, CAR-T)作为新型治疗模式备受关注。CAR-T细胞的治疗基础为白血病细胞上的特异性抗原，即免疫治疗靶点。笔者对近年来白血病CAR-T细胞治疗靶点的相关研究进行综述。<br />
Leukemia is defined as malignant neoplasm of blood-forming tissues, which characterized as abnormal proliferation of leukocytes. The main treatment includes chemotherapy, allogeneic hematopoietic stem cell transplantation, immunotherapy and cellular therapy. Recently, immunotherapy, is an emerging novel therapy and has achieved dramatic success in clinical practice, especially for chimeric antigen receptor (CAR) T-cell. The basic of CAR-T therapy is tumor specific antigen, this review summarizes related potential tumor antigens in leukemia for CAR-T therapy.
%K 嵌合抗原受体T细胞，白血病，抗原<br>Chimeric Antigen Receptor T Cell
%K Leukemia
%K Antigen
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=48003